Business · Companies · 1 hr ago

Transasia Bio-Medicals considers selling up to 20% stake to raise $200 million

Transasia Bio-Medicals considers selling up to 20% stake to raise $200 million

Transasia Bio-Medicals is considering selling up to 20% of the company to raise $150 million to $200 million.

The Mumbai-based company makes medical equipment and diagnostic products, including tests for blood and other samples.

Several private equity firms have expressed interest, including TPG, Warburg Pincus, ChrysCapital, Motilal Oswal and Quadria Capital.

The talks are at an early stage, and the exact terms have not been decided.

The fundraising could combine new shares and existing shares, with O3 Capital helping arrange the deal.

Founded in 1979, Transasia grew from distributing imported equipment into a manufacturer and is part of the Erba group, which operates in 150 countries.

The proposed sale would be its first external capital raise, as India’s medtech market is projected to grow from $12 billion in FY24 to $50 billion by 2030.

1 source

Related

What people are saying

Person familiar with the matterPerson familiar with the discussions
The round is likely a mix of primary and secondary share sale although the exact structures are subject to change depending on the incoming investor. O3 Capital is helping the company with the fundraise.
via Mint